Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
Status:
Completed
Trial end date:
2018-01-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of the drug isradipine for cognitive
enhancement in patients diagnosed with schizophrenia and schizoaffective disorder.